HealthcarePharmaceuticals

Dengue Vaccine Market | Size | Forecast (2019-2025) | Analysis

Press Release

MarketResearchNest.com ads “Global Dengue Vaccine Market Insights, Forecast to 2025” new report to its research database. The report spread across 110 pages with multiple tables and figures in it.

The Aedes aegypti mosquito is responsible for transmitting the dengue virus (DENV). The virus that causes dengue belongs to the Flavivirus genus of the Flaviviridae family. Dengue fever resembles influenza and affects adults, children, as well as infants, but it is rarely fatal. However, dengue hemorrhagic fever is a potentially fatal complication because of multiple factors such as fluid accumulation, severe bleeding, organ impairment, or plasma leaking.

With the increasing population density and global warming, there is a rapid growth in the prevalence of dengue, especially in the tropical and subtropical regions across the world. According to the National Institute of Health, approximately 0.05 to 0.2 billion cases of dengue infections are reported annually and the mortality rate due to dengue was above 20,000. The report has identified the rapid growth in disease incidences as one of the primary factors that will fuel the growth of the dengue vaccine market in the coming years. The prevalence of dengue is present in more than 125 countries across the world and the rising prevalence of dengue will drive the market during the forecast period.

The dengue vaccine market is marginally concentrated due to the presence and dominance of the established players. Several companies are investing in RandD to develop more advanced products and expand their product portfolio. Several organizations are merging for research and making enormous efforts to develop vaccines that can challenge the Sanofi Pasteur’s exclusivity in the dengue treatment market. Moreover, several organizations are making huge investments in RandD to develop novel treatment options.

The Americas will be the major revenue contributor to the dengue vaccine market owing to the increasing incidences of dengue cases. The dengue treatment market in the Americas will profit from the bilateral program, Indo-U.S. Vaccine Action Program (VAP), which is concentrated on activities related to immunization and vaccine-related research.

The global Dengue Vaccine market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Dengue Vaccine market based on company, product type, end user and key regions.

Request a sample copy @

https://www.marketresearchnest.com/report/requestsample/662117

This report studies the global market size of Dengue Vaccine in key regions like North America, Europe, Asia Pacific, Central and South America and Middle East and Africa, focuses on the consumption of Dengue Vaccine in these regions.

This research report categorizes the global Dengue Vaccine market by top players/brands, region, type and end user. This report also studies the global Dengue Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report:             

  • GlaxoSmithKline
  • Merck Sharp and Dohme
  • Sanofi
  • Takeda Pharmaceuticals
  • GeneOne Life Sciences
  • Medigen Biologics
  • Panacea Biotec
  • Sun Pharmaceutical
  • S NIH
  • Vabiotec

Browse full table of contents and data tables @

https://www.marketresearchnest.com/Global-Dengue-Vaccine-Market-Insights-Forecast-to-2025.html

Market size by Product

CYD-TDV

DENVax or TAK-003

TetraVax-DV

TDENV PIV

V180

DNA vaccines

Market size by End User

Government institutions

Hospitals

NGOs

Order a Purchase Report Copy @

https://www.marketresearchnest.com/report/purchase/662117

Table of Contents

1 Study Coverage

1.1 Dengue Vaccine Product

1.2 Market Segments

1.3 Key Manufacturers Covered

1.4 Market by Type

1.4.1 Global Dengue Vaccine Market Size Growth Rate by Product

1.4.2 Organic

1.4.3 Conventional

1.5 Market by End User

1.5.1 Global Dengue Vaccine Market Size Growth Rate by End User

1.5.2 Retailer

1.5.3 Industrial

1.5.4 Healthcare

1.5.5 Cleaning And Cooking

1.6 Study Objectives

1.7 Years Considered

2 Executive Summary

2.1 Global Dengue Vaccine Market Size

2.1.1 Global Dengue Vaccine Revenue 2014-2025

2.1.2 Global Dengue Vaccine Sales 2014-2025

2.2 Dengue Vaccine Growth Rate by Regions

2.2.1 Global Dengue Vaccine Sales by Regions

2.2.2 Global Dengue Vaccine Revenue by Regions

3 Breakdown Data by Manufacturers

3.1 Dengue Vaccine Sales by Manufacturers

3.1.1 Dengue Vaccine Sales by Manufacturers

3.1.2 Dengue Vaccine Sales Market Share by Manufacturers

3.1.3 Global Dengue Vaccine Market Concentration Ratio (CR5 and HHI)

3.2 Dengue Vaccine Revenue by Manufacturers

3.2.1 Dengue Vaccine Revenue by Manufacturers (2014-2019)

3.2.2 Dengue Vaccine Revenue Share by Manufacturers (2014-2019)

3.3 Dengue Vaccine Price by Manufacturers

3.4 Dengue Vaccine Manufacturing Base Distribution, Product Types

3.4.1 Dengue Vaccine Manufacturers Manufacturing Base Distribution, Headquarters

3.4.2 Manufacturers Dengue Vaccine Product Type

3.4.3 Date of International Manufacturers Enter into Dengue Vaccine Market

3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

4.1 Global Dengue Vaccine Sales by Product

4.2 Global Dengue Vaccine Revenue by Product

4.3 Dengue Vaccine Price by Product

5 Breakdown Data by End User

5.1 Overview

5.2 Global Dengue Vaccine Breakdown Data by End User

6 North America

6.1 North America Dengue Vaccine by Countries

6.1.1 North America Dengue Vaccine Sales by Countries

6.1.2 North America Dengue Vaccine Revenue by Countries

6.1.3 United States

6.1.4 Canada

6.1.5 Mexico

6.2 North America Dengue Vaccine by Product

6.3 North America Dengue Vaccine by End User

7 Europe

7.1 Europe Dengue Vaccine by Countries

7.1.1 Europe Dengue Vaccine Sales by Countries

7.1.2 Europe Dengue Vaccine Revenue by Countries

7.1.3 Germany

7.1.4 France

7.1.5 UK

7.1.6 Italy

7.1.7 Russia

7.2 Europe Dengue Vaccine by Product

7.3 Europe Dengue Vaccine by End User

About Us:

MarketResearchNest.com is the most comprehensive collection of market research products and services on the Web. We offer reports from almost all top publishers and update our collection on daily basis to provide you with instant online access to the world’s most complete and recent database of expert insights on Global industries, organizations, products, and trends.

Contact Us

Mr. Jeet Jain

Sales Manager

[email protected]

+1-240-284-8070

+44-20-3290-4151

Connect with us:  Google+ | LinkedIn | Twitter | Facebook

Tags

Related Articles

Close